picsi dish
Devicetheses techniques to selection mature and lowest DNA fragmentation sperm for injection in oocyte
Other names: zymot device
NCT Number: NCT07240779
our study explores the effectiveness of two advanced sperm selection techniques-PICSI and the ZyMot microfluidic device-in improving outcomes of Intracytoplasmic Sperm Injection (ICSI). It aims to compare their impact on fertilization rates, embryo quality, and clinical pregnancy success, helping determine which method offers superior results in assisted reproductive technology.
Trial opening soon.
Get Notified20 year–39 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-
Exclusion criteria
׃-
theses techniques to selection mature and lowest DNA fragmentation sperm for injection in oocyte
Other names: zymot device
Time frame: 6-9 weeks after embryo transfer.
1• clinical pregnancy rate:- defined as the presence of a fetal heartbeat or gestational sac.
Time frame: 1-After 6 weeks of gestation.
1- Miscarriage rate: Defined as pregnancy loss following confirmation of clinical pregnancy. Unit of Measure: Percentage (%)
Contact information is provided by the study sponsor or research team.
Sunrise Fertility Center
Other
Evaluating the Use of Advanced Sperm Selection Methods on ICSI Procedure Outcomes by Physiological Intracytoplasmic Sperm Injection (PICSI) Verses ZyMot Device
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.